+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liposomal Drug Delivery Devices Global Market Report 2021: COVID-19 Growth and Change to 2030

  • PDF Icon

    Report

  • May 2021
  • Region: Global
  • The Business Research Company
  • ID: 5321419
Liposomal Drug Delivery Devices Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global liposomal drug delivery devices market.







This report focuses on the liposomal drug delivery devices market which is experiencing strong growth. The report gives a guide to the liposomal drug delivery devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the liposomal drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Liposomal Drug Delivery Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider liposomal drug delivery devices market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The liposomal drug delivery devices market section of the report gives context. It compares the liposomal drug delivery devices market with other segments of the liposomal drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, liposomal drug delivery devices indicators comparison.

Scope

Markets Covered:

1) By Type: Liposomal Doxorubicin; Liposomal Paclitaxel; Liposomal Amphotericin B; Others 2) By Application: Fungal Diseases; Cancer Therapy; Pain Management; Viral Vaccines; Photodynamic Therapy 3) By End User: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Others

Companies Mentioned: Fudan-Zhangjiang; Pacira; Johnson and Johnson; Gilead Sciences; Novartis

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Liposomal Drug Delivery Devices Market

What is the estimated value of the Global Liposomal Drug Delivery Devices Market?

The Global Liposomal Drug Delivery Devices Market was estimated to be valued at $3.64 billion in 2021.

What is the growth rate of the Global Liposomal Drug Delivery Devices Market?

The growth rate of the Global Liposomal Drug Delivery Devices Market is 10.3%, with an estimated value of $5.39 billion by 2025.

What is the forecasted size of the Global Liposomal Drug Delivery Devices Market?

The Global Liposomal Drug Delivery Devices Market is estimated to be worth $5.39 billion by 2025.

Who are the key companies in the Global Liposomal Drug Delivery Devices Market?

Key companies in the Global Liposomal Drug Delivery Devices Market include Fudan, Zhangjiang, Pacira, Johnson and Johnson, Gilead Sciences, Novartis, Luye Pharma, CSPC and Teva Pharmaceutical.

Table of Contents

1. Executive Summary2. Liposomal Drug Delivery Devices Market Characteristics3. Liposomal Drug Delivery Devices Market Trends and Strategies4. Impact of COVID-19 on Liposomal Drug Delivery Devices
5. Liposomal Drug Delivery Devices Market Size and Growth
5.1. Global Liposomal Drug Delivery Devices Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Liposomal Drug Delivery Devices Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Liposomal Drug Delivery Devices Market Segmentation
6.1. Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others
6.2. Global Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy
6.3. Global Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Others

7. Liposomal Drug Delivery Devices Market Regional and Country Analysis
7.1. Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Liposomal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Liposomal Drug Delivery Devices Market
8.1. Asia-Pacific Liposomal Drug Delivery Devices Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Liposomal Drug Delivery Devices Market
9.1. China Liposomal Drug Delivery Devices Market Overview
9.2. China Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Liposomal Drug Delivery Devices Market
10.1. India Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Liposomal Drug Delivery Devices Market
11.1. Japan Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Liposomal Drug Delivery Devices Market
12.1. Australia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Liposomal Drug Delivery Devices Market
13.1. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Liposomal Drug Delivery Devices Market
14.1. South Korea Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Liposomal Drug Delivery Devices Market
15.1. Western Europe Liposomal Drug Delivery Devices Market Overview
15.2. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Liposomal Drug Delivery Devices Market
16.1. UK Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Liposomal Drug Delivery Devices Market
17.1. Germany Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Liposomal Drug Delivery Devices Market
18.4. France Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Liposomal Drug Delivery Devices Market
19.1. Eastern Europe Liposomal Drug Delivery Devices Market Overview
19.2. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Liposomal Drug Delivery Devices Market
20.1. Russia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Liposomal Drug Delivery Devices Market
21.1. North America Liposomal Drug Delivery Devices Market Overview
21.2. North America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Liposomal Drug Delivery Devices Market
22.1. USA Liposomal Drug Delivery Devices Market Overview
22.2. USA Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Liposomal Drug Delivery Devices Market
23.1. South America Liposomal Drug Delivery Devices Market Overview
23.2. South America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Liposomal Drug Delivery Devices Market
24.1. Brazil Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Liposomal Drug Delivery Devices Market
25.1. Middle East Liposomal Drug Delivery Devices Market Overview
25.2. Middle East Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Liposomal Drug Delivery Devices Market
26.1. Africa Liposomal Drug Delivery Devices Market Overview
26.2. Africa Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Liposomal Drug Delivery Devices Market Competitive Landscape and Company Profiles
27.1. Liposomal Drug Delivery Devices Market Competitive Landscape
27.2. Liposomal Drug Delivery Devices Market Company Profiles
27.2.1. Fudan-Zhangjiang
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pacira
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Johnson and Johnson
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Gilead Sciences
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Novartis
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Liposomal Drug Delivery Devices Market29. Liposomal Drug Delivery Devices Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the liposomal drug delivery devices market are, Fudan-Zhangjiang, Pacira, Johnson and Johnson, Gilead Sciences, Novartis, Luye Pharma, CSPC, Ipsen (Onivyde), and Teva Pharmaceutical.

The global liposomal drug delivery devices market is expected to grow from $3.304 billion in 2020 to $3.644 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.389 billion in 2025 at a CAGR of 10%.

The liposomal drug delivery devices market consists of sales of liposomal drug delivery devices and related services by entities (organizations, sole traders, and partnerships) that manufacture liposomal drug delivery devices. Liposomes are microscopic colloidal spheres that are used to deliver drug molecules to the site of action. Liposomal drug delivery devices are used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics, and home care settings.

Several big companies are undertaking various strategic initiatives such as collaborations and new product development, which is likely to become a major trend in the liposomal drug delivery devices market. Various companies are coming together to develop liposomal drug delivery systems to expand their product portfolio and operations worldwide. For instance, in June 2018, Virpax Pharmaceuticals, Inc., a company based in West Chester, Pennsylvania engaged in manufacturing drug delivery systems, signed a license agreement with LipoCure to manufacture pain management products using the company’s liposome drug delivery technology. Virpax Pharmaceuticals, Inc. develops pharmaceuticals products for pain management using new drug delivery systems. In March 2020, FUJIFILM Corporation announced its decision to offer contract services of process development and manufacturing of liposome formulations to its partners seeking drug delivery formulations that are designed to deliver the therapeutic to the affected sites.

The liposomal drug delivery devices market covered in this report is segmented by type into liposomal doxorubicin; liposomal paclitaxel; liposomal amphotericin B; others. It is also segmented by application into fungal diseases; cancer therapy; pain management; viral vaccines; photodynamic therapy and by end user into hospitals; diagnostic centers; ambulatory surgery centers/clinics; others.

In July 2020, Croda International, Plc, a UK-based specialty chemicals company, acquired Avanti Polar Lipids, Inc. for $260 million. The acquisition is expected to expand life sciences products, cGMP production capabilities, and pharmaceutical services for biotechnology, life science, and expand customers for Croda International. Avanti Polar Lipids Inc. is a USA-based company that specializes in lipid-based drug delivery technology for next-generation pharmaceuticals.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the liposomal drug delivery devices market during the forecast period. Liposomal drug delivery systems are used as targeted therapy for cancer treatment in radiation therapy, chemotherapy, and surgical resection. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the liposomal drug delivery devices market over the forthcoming years.

The high cost of liposomal drug delivery devices is expected to limit the growth of the market during the forecast period. The high cost of devices makes liposomal treatment more expensive and unaffordable for patients, thereby hindering the growth of the market. For instance, according to the Journal of Biotechnology & Biomaterials, lipid/liposomal drug delivery systems are expensive to produce attributing to their high production cost. The high cost of products results from the high cost associated with the raw materials used in lipid excipients and the requirement of expensive equipment to increase manufacturing. Furthermore, according to the ScienceDirect Journal, liposomal drug delivery is the most expensive treatment for topical disorders such as psoriasis, atopic dermatitis, and skin cancer.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Fudan-Zhangjiang
  • Pacira
  • Johnson and Johnson
  • Gilead Sciences
  • Novartis
  • Luye Pharma
  • CSPC
  • Ipsen (Onivyde)
  • Teva Pharmaceutical
  • Sigma-Tau Group
  • Sun Pharmaceutical
  • T&T Scientific Corporation

Methodology

Loading
LOADING...